Viewing Study NCT02779569


Ignite Creation Date: 2025-12-24 @ 10:46 PM
Ignite Modification Date: 2026-01-04 @ 9:23 AM
Study NCT ID: NCT02779569
Status: UNKNOWN
Last Update Posted: 2017-11-08
First Post: 2016-05-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Clinical Trial Evaluating the Efficacy of Ultra Low Dose of Decitabine in Myelodysplastic Syndromes (MDS)
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module